pregnancy semaglutide Study links GLP-1 use to some risks — but the research has key caveats Impact of semaglutide exposure on

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed financial ties to obesity drugmakers, a paper finds.

Various pharmaceutical and research-focused manufacturers now package peptide formulations under different product systems, including multi-dose pen devices

Learn about the differences between these treatments, how each works, and what else to consider.

For the 9 mg dose, the weight reduction was 26.4%, compared to 2.1% in the placebo group

We believe in this ability to deliver real precision medicine to patients at scale for affordable prices, though prices have not yet been disclosed

That picture has changed significantly in 2026.